La chaîne d'options affiche les données clés des options sur actions de Talos Energy à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Talos Energy..

Talos Energy (NYSE:TALO) Stock, Chaîne d'Options

Talos Energy

Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.

Talos Energy Inc

Talon Energy Ltd

TALON INTERNATIONAL INC by Talon International, Inc.

Talon International Inc

Talon Metals Corp

<p><strong>Rollins</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROL#NYSE">ROL</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-04-23. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Rollins will report an <strong>earnings per share</strong> (EPS) of $0.22. </p>
<p>The market awaits Rollins's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings Track Record</h3>
<p>The company's EPS missed by $0.00 in the last quarter, leading to a 3.63% increase in the share price on the following day.</p>
<p>Here's a look at Rollins's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.23</td>
<td>0.30</td>
<td>0.27</td>
<td>0.2</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.23</td>
<td>0.29</td>
<td>0.27</td>
<td>0.2</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>4.0%</td>
<td>-7.000000000000001%</td>
<td>-6.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745337727_0.png" alt="eps graph" /></p>
<h3>Rollins Share Price Analysis</h3>
<p>Shares of Rollins were trading at $54.73 as of April 21. Over the last 52-week period, shares are up 29.66%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Analyst Views on Rollins</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Rollins.</p>
<p>With 4 analyst ratings, Rollins has a consensus rating of Neutral. The average one-year price target is $54.0, indicating a potential 1.33% downside.</p>
<h3>Analyzing Ratings Among Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of Veralto, Clean Harbors and Tetra Tech, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Veralto, with an average 1-year price target of $107.6, suggesting a potential 96.6% upside.</li>
<li>Analysts currently favor an Buy trajectory for Clean Harbors, with an average 1-year price target of $255.5, suggesting a potential 366.84% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Tetra Tech, with an average 1-year price target of $39.5, suggesting a potential 27.83% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
<p>In the peer analysis summary, key metrics for Veralto, Clean Harbors and Tetra Tech are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rollins</td>
<td>Neutral</td>
<td>10.35%</td>
<td>$426.71M</td>
<td>7.98%</td>
</tr>
<tr>
<td>Veralto</td>
<td>Buy</td>
<td>4.43%</td>
<td>$801M</td>
<td>11.37%</td>
</tr>
<tr>
<td>Clean Harbors</td>
<td>Buy</td>
<td>6.95%</td>
<td>$427.61M</td>
<td>3.29%</td>
</tr>
<tr>
<td>Tetra Tech</td>
<td>Outperform</td>
<td>15.66%</td>
<td>$221.48M</td>
<td>0.04%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Rollins ranks in the middle among its peers for revenue growth, with a growth rate of 10.35%. It is at the bottom for gross profit at $426.71M. Rollins is also at the bottom for return on equity at 7.98%.</p>
<h3>Get to Know Rollins Better</h3>
<p>Rollins is a global leader in route-based pest control services, with operations primarily in the United States, as well as in North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US, which boasts near national coverage, and in Canada. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on the US and Canadian markets.</p>
<h3>Rollins: A Financial Overview</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Rollins's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately <strong>10.35%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>12.7%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>7.98%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Rollins's ROA excels beyond industry benchmarks, reaching <strong>3.75%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Rollins's debt-to-equity ratio is below the industry average at <strong>0.61</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/ROL/earnings"><strong>To track all earnings releases for Rollins visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

A Look Ahead: Rollins's Earnings Forecast

<p>Piper Sandler  analyst Mark Lear   maintains Occidental Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) with a Neutral and lowers the price target from $50 to $48.</p>


News

Price Target

Analyst Ratings

Piper Sandler Maintains Neutral on Occidental Petroleum, Lowers Price Target to $48

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Bank of America</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BAC, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 20 uncommon options trades for Bank of America.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 55% bullish and 40%, bearish.</p>
<p>Out of all of the special options we uncovered, 7 are puts, for a total amount of $398,513, and 13 are calls, for a total amount of $858,666.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $33.0 and $50.0 for Bank of America, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Bank of America options trades today is 9293.85 with a total volume of 8,752.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Bank of America's big money trades within a strike price range of $33.0 to $50.0 over the last 30 days.</p>
<h3>Bank of America Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745337719_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$1.93</td>
<td>$1.9</td>
<td>$1.91</td>
<td>$38.00</td>
<td>$191.0K</td>
<td>9.5K</td>
<td>1.1K</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$5.05</td>
<td>$4.95</td>
<td>$4.95</td>
<td>$38.00</td>
<td>$148.5K</td>
<td>2.3K</td>
<td>300</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$1.32</td>
<td>$1.3</td>
<td>$1.3</td>
<td>$38.00</td>
<td>$130.0K</td>
<td>9.3K</td>
<td>98</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$0.8</td>
<td>$0.78</td>
<td>$0.78</td>
<td>$34.00</td>
<td>$91.7K</td>
<td>6.0K</td>
<td>1.1K</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/30/25</td>
<td>$1.23</td>
<td>$1.22</td>
<td>$1.23</td>
<td>$37.00</td>
<td>$73.8K</td>
<td>453</td>
<td>1.2K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Bank of America</h3>
<p>Bank of America is one of the largest financial institutions in the United States, with more than $3.2 trillion in assets. It is organized into four major segments: consumer banking, global wealth and investment management, global banking, and global markets. Bank of America's consumer-facing lines of business include its network of branches and deposit-gathering operations, retail lending products, credit and debit cards, and small-business services. The company's Merrill Lynch operations provide brokerage and wealth-management services, as does its private bank. Wholesale lines of business include investment banking, corporate and commercial real estate lending, and capital markets operations. Bank of America has operations in several countries but is primarily US-focused.</p>
<p>Having examined the options trading patterns of Bank of America, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is Bank of America Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 12,472,018, the BAC's price is up by 2.38%, now at $37.8. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 85 days.</li>
</ul>
<h3>What The Experts Say On Bank of America</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $50.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Bank of America with a target price of $50.<br />
&#x2A; Maintaining their stance, an analyst from Keefe, Bruyette &amp; Woods continues to hold a Outperform rating for Bank of America, targeting a price of $52.<br />
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on Bank of America, which currently sits at a price target of $47.<br />
&#x2A; Maintaining their stance, an analyst from Argus Research continues to hold a Buy rating for Bank of America, targeting a price of $47.<br />
&#x2A; An analyst from Barclays persists with their Overweight rating on Bank of America, maintaining a target price of $54. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Bank of America, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

Check Out What Whales Are Doing With BAC

<p>Waste Connections (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WCN#NYSE">WCN</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-04-23. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Waste Connections will report an <strong>earnings per share</strong> (EPS) of $1.10.</p>
<p>Anticipation surrounds Waste Connections's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company missed EPS by $0.03, which was followed by a 0.59% drop in the share price the next day.</p>
<p>Here's a look at Waste Connections's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.19</td>
<td>1.29</td>
<td>1.17</td>
<td>1</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.16</td>
<td>1.35</td>
<td>1.24</td>
<td>1.04</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>-1.0%</td>
<td>-2.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745337718_0.png" alt="eps graph" /></p>
<h3>Waste Connections Share Price Analysis</h3>
<p>Shares of Waste Connections were trading at $194.57 as of April 21. Over the last 52-week period, shares are up 18.47%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/WCN/earnings"><strong>To track all earnings releases for Waste Connections visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Outlook For Waste Connections

<p>Financial giants have made a conspicuous bullish move on Chevron. Our analysis of options history for Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) revealed 9 unusual trades.</p>
<p>Delving into the details, we found 66% of traders were bullish, while 22% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $213,946, and 4 were calls, valued at $157,200.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90.0 to $145.0 for Chevron over the recent three months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Chevron options trades today is 1355.56 with a total volume of 1,219.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Chevron's big money trades within a strike price range of $90.0 to $145.0 over the last 30 days.</p>
<h3>Chevron Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745337714_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/02/25</td>
<td>$1.18</td>
<td>$1.08</td>
<td>$1.16</td>
<td>$130.00</td>
<td>$98.2K</td>
<td>148</td>
<td align="right">857</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$10.4</td>
<td>$10.2</td>
<td>$10.3</td>
<td>$130.00</td>
<td>$48.4K</td>
<td>382</td>
<td align="right">69</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$47.0</td>
<td>$44.55</td>
<td>$47.0</td>
<td>$90.00</td>
<td>$47.0K</td>
<td>28</td>
<td align="right">0</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$6.85</td>
<td>$6.75</td>
<td>$6.85</td>
<td>$135.00</td>
<td>$34.2K</td>
<td>1.6K</td>
<td align="right">64</td>
</tr>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$9.0</td>
<td>$8.9</td>
<td>$8.9</td>
<td>$140.00</td>
<td>$33.8K</td>
<td>8.6K</td>
<td align="right">79</td>
</tr>
</tbody>
</table>
</p>
<h3>About Chevron</h3>
<p>Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.0 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.7 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2024 stood at 9.8 billion barrels of oil equivalent, including 5.1 billion barrels of liquids and 28.4 trillion cubic feet of natural gas.</p>
<p>After a thorough review of the options trading surrounding Chevron, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Chevron's Current Market Status</h3>
<ul>
<li>With a volume of 2,232,866, the price of CVX is up 2.04% at $136.46. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 10 days.</li>
</ul>
<h3>What Analysts Are Saying About Chevron</h3>
<p>A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $167.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from UBS persists with their Buy rating on Chevron, maintaining a target price of $185.<br />
&#x2A; An analyst from Scotiabank downgraded its action to Sector Perform with a price target of $143.<br />
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Chevron, which currently sits at a price target of $173. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Chevron with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Spotlight on Chevron: Analyzing the Surge in Options Activity

<p>ResMed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-04-23. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that ResMed will report an <strong>earnings per share</strong> (EPS) of $2.36.</p>
<p>Anticipation surrounds ResMed's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Earnings History Snapshot</h3>
<p>In the previous earnings release, the company beat EPS by $0.12, leading to a 8.33% drop in the share price the following trading session.</p>
<p>Here's a look at ResMed's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.31</td>
<td>2.04</td>
<td>2.06</td>
<td>1.91</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.43</td>
<td>2.20</td>
<td>2.08</td>
<td>2.13</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-8.0%</td>
<td>7.000000000000001%</td>
<td>4.0%</td>
<td>19.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745337709_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of ResMed were trading at $210.87 as of April 21. Over the last 52-week period, shares are up 15.82%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Views on ResMed</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on ResMed.</p>
<p>Analysts have provided ResMed with 5 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $267.0, suggesting a potential 26.62% upside.</p>
<h3>Peer Ratings Overview</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of IDEXX Laboratories, GE HealthCare Techs and DexCom, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for IDEXX Laboratories, with an average 1-year price target of $507.0, suggesting a potential 140.43% upside.</li>
<li>Analysts currently favor an Buy trajectory for GE HealthCare Techs, with an average 1-year price target of $104.33, suggesting a potential 50.52% downside.</li>
<li>Analysts currently favor an Buy trajectory for DexCom, with an average 1-year price target of $97.8, suggesting a potential 53.62% downside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
<p>The peer analysis summary outlines pivotal metrics for IDEXX Laboratories, GE HealthCare Techs and DexCom, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>ResMed</td>
<td>Outperform</td>
<td>10.26%</td>
<td>$751.27M</td>
<td>6.60%</td>
</tr>
<tr>
<td>IDEXX Laboratories</td>
<td>Neutral</td>
<td>5.84%</td>
<td>$570.66M</td>
<td>13.45%</td>
</tr>
<tr>
<td>GE HealthCare Techs</td>
<td>Buy</td>
<td>2.17%</td>
<td>$2.27B</td>
<td>8.60%</td>
</tr>
<tr>
<td>DexCom</td>
<td>Buy</td>
<td>7.64%</td>
<td>$655.80M</td>
<td>7.43%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>ResMed ranks at the top for Revenue Growth and Gross Profit among its peers. It is in the middle for Return on Equity.</p>
<h3>All You Need to Know About ResMed</h3>
<p>ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.</p>
<h3>ResMed's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> ResMed displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately <strong>10.26%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.</p>
<p><strong>Net Margin:</strong> ResMed's net margin excels beyond industry benchmarks, reaching <strong>26.88%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> ResMed's ROE excels beyond industry benchmarks, reaching <strong>6.6%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> ResMed's ROA excels beyond industry benchmarks, reaching <strong>4.8%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> ResMed's debt-to-equity ratio is below the industry average at <strong>0.16</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/RMD/earnings"><strong>To track all earnings releases for ResMed visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Look Ahead: ResMed's Earnings Forecast

<p>Investors with significant funds have taken a bullish position in Caterpillar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>), a development that retail traders should be aware of.</p>
<p>This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga. The exact nature of these investors remains a mystery, but such a major move in CAT usually indicates foreknowledge of upcoming events.</p>
<p>Today, Benzinga's options scanner identified 11 options transactions for Caterpillar. This is an unusual occurrence. The sentiment among these large-scale traders is mixed, with 45% being bullish and 45% bearish. Of all the options we discovered, 10 are puts, valued at $576,182, and there was a single call, worth $51,780.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $270.0 and $350.0 for Caterpillar, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Caterpillar's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Caterpillar's whale activity within a strike price range from $270.0 to $350.0 in the last 30 days. </p>
<h3>Caterpillar Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745337709_0_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CAT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$11.2</td>
<td>$11.05</td>
<td>$11.05</td>
<td>$270.00</td>
<td>$165.7K</td>
<td>345</td>
<td align="right">151</td>
</tr>
<tr>
<td>CAT</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/25/25</td>
<td>$17.95</td>
<td>$15.45</td>
<td>$16.6</td>
<td>$305.00</td>
<td>$81.3K</td>
<td>125</td>
<td align="right">49</td>
</tr>
<tr>
<td>CAT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$36.2</td>
<td>$35.4</td>
<td>$35.4</td>
<td>$300.00</td>
<td>$70.8K</td>
<td>1.2K</td>
<td align="right">46</td>
</tr>
<tr>
<td>CAT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/25/25</td>
<td>$12.9</td>
<td>$12.15</td>
<td>$12.33</td>
<td>$300.00</td>
<td>$52.1K</td>
<td>77</td>
<td align="right">84</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$2.24</td>
<td>$1.73</td>
<td>$1.72</td>
<td>$340.00</td>
<td>$51.7K</td>
<td>1.9K</td>
<td align="right">300</td>
</tr>
</tbody>
</table>
</p>
<h3>About Caterpillar</h3>
<p>Caterpillar is the world's leading manufacturer of construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines and diesel-electric locomotives. Its reporting segments are: construction industries (40% sales/47% operating profit, or OP), resource industries (20% sales/19% OP), and energy &amp; transportation (40% sales/34% OP). Market share approaches 20% across many products. Caterpillar operates a captive finance subsidiary to facilitate sales. The firm has global reach (46% US sales/54% ex-US). Construction skews more domestic, while the other divisions are more geographically diversified. An independent network of 156 dealers operates approximately 2,800 facilities, giving Caterpillar reach into about 190 countries for sales and support services.</p>
<p>After a thorough review of the options trading surrounding Caterpillar, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is Caterpillar Standing Right Now?</h3>
<ul>
<li>With a volume of 548,431, the price of CAT is up 1.32% at $288.51. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 8 days.</li>
</ul>
<h3>What Analysts Are Saying About Caterpillar</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $331.4.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Caterpillar with a target price of $380.<br />
&#x2A; Reflecting concerns, an analyst from UBS lowers its rating to Sell with a new price target of $243.<br />
&#x2A; Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Caterpillar, targeting a price of $320.<br />
&#x2A; Maintaining their stance, an analyst from DA Davidson continues to hold a Neutral rating for Caterpillar, targeting a price of $325.<br />
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Caterpillar with a target price of $389. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Caterpillar with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Caterpillar Options Trading: A Deep Dive into Market Sentiment

<p>Penumbra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEN#NYSE">PEN</a>) is preparing to release its quarterly earnings on Wednesday, 2025-04-23. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Penumbra to report an <strong>earnings per share</strong> (EPS) of $0.67.</p>
<p>The announcement from Penumbra is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company beat EPS by $0.08, which was followed by a 12.03% increase in the share price the next day.</p>
<p>Here's a look at Penumbra's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.89</td>
<td>0.69</td>
<td>0.56</td>
<td>0.38</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.97</td>
<td>0.85</td>
<td>0.64</td>
<td>0.41</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>12.0%</td>
<td>8.0%</td>
<td>-3.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745337697_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Penumbra were trading at $270.64 as of April 21. Over the last 52-week period, shares are up 32.52%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Insights on Penumbra</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Penumbra.</p>
<p>Analysts have given Penumbra a total of 12 ratings, with the consensus rating being Outperform. The average one-year price target is $312.17, indicating a potential 15.35% upside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Globus Medical, Hologic and Masimo, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Globus Medical, with an average 1-year price target of $90.4, suggesting a potential 66.6% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Hologic, with an average 1-year price target of $81.0, suggesting a potential 70.07% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Masimo, with an average 1-year price target of $210.0, suggesting a potential 22.41% downside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for Globus Medical, Hologic and Masimo, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Penumbra</td>
<td>Outperform</td>
<td>10.83%</td>
<td>$210.72M</td>
<td>2.99%</td>
</tr>
<tr>
<td>Globus Medical</td>
<td>Neutral</td>
<td>6.61%</td>
<td>$393.86M</td>
<td>0.64%</td>
</tr>
<tr>
<td>Hologic</td>
<td>Neutral</td>
<td>0.86%</td>
<td>$580.50M</td>
<td>4.06%</td>
</tr>
<tr>
<td>Masimo</td>
<td>Outperform</td>
<td>9.44%</td>
<td>$244.70M</td>
<td>-27.80%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Penumbra ranks highest in Revenue Growth and Gross Profit among its peers. It also has the highest Return on Equity. However, it has the lowest Consensus rating.</p>
<h3>Unveiling the Story Behind Penumbra</h3>
<p>Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.</p>
<h3>Penumbra's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Penumbra showcased positive performance, achieving a revenue growth rate of <strong>10.83%</strong> as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> Penumbra's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>10.68%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Penumbra's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>2.99%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Penumbra's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>2.24%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Penumbra's debt-to-equity ratio is below the industry average at <strong>0.19</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/PEN/earnings"><strong>To track all earnings releases for Penumbra visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Examining the Future: Penumbra's Earnings Outlook

<p>Barclays  analyst Nicholas Campanella   maintains Consolidated Edison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>) with a Underweight and raises the price target from $95 to $100.</p>


Barclays Maintains Underweight on Consolidated Edison, Raises Price Target to $100

<p>Piper Sandler  analyst Mark Lear   maintains Murphy Oil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUR#NYSE">MUR</a>) with a Overweight and raises the price target from $34 to $35.</p>


Piper Sandler Maintains Overweight on Murphy Oil, Raises Price Target to $35

<p>Teledyne Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-04-23. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Teledyne Technologies will report an <strong>earnings per share</strong> (EPS) of $5.02.</p>
<p>Investors in Teledyne Technologies are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Earnings Track Record</h3>
<p>In the previous earnings release, the company beat EPS by $0.29, leading to a 0.67% increase in the share price the following trading session.</p>
<p>Here's a look at Teledyne Technologies's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>5.23</td>
<td>4.97</td>
<td>4.49</td>
<td>4.63</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>5.52</td>
<td>5.10</td>
<td>4.58</td>
<td>4.55</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>1.0%</td>
<td>-0.0%</td>
<td>4.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745337671_0.png" alt="eps graph" /></p>
<h3>Tracking Teledyne Technologies's Stock Performance</h3>
<p>Shares of Teledyne Technologies were trading at $453.35 as of April 21. Over the last 52-week period, shares are up 26.47%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Opinions on Teledyne Technologies</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Teledyne Technologies.</p>
<p>With 2 analyst ratings, Teledyne Technologies has a consensus rating of Buy. The average one-year price target is $592.5, indicating a potential 30.69% upside.</p>
<h3>Comparing Ratings Among Industry Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of Keysight Techs, Trimble and Zebra Technologies, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Keysight Techs, with an average 1-year price target of $184.0, suggesting a potential 59.41% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Trimble, with an average 1-year price target of $90.0, suggesting a potential 80.15% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Zebra Technologies, with an average 1-year price target of $336.78, suggesting a potential 25.71% downside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
<p>Within the peer analysis summary, vital metrics for Keysight Techs, Trimble and Zebra Technologies are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Teledyne Technologies</td>
<td>Buy</td>
<td>5.42%</td>
<td>$642.70M</td>
<td>2.07%</td>
</tr>
<tr>
<td>Keysight Techs</td>
<td>Outperform</td>
<td>3.10%</td>
<td>$820M</td>
<td>3.28%</td>
</tr>
<tr>
<td>Trimble</td>
<td>Outperform</td>
<td>12.29%</td>
<td>$575.60M</td>
<td>1.55%</td>
</tr>
<tr>
<td>Zebra Technologies</td>
<td>Neutral</td>
<td>32.21%</td>
<td>$648M</td>
<td>4.65%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Teledyne Technologies ranks:<br />
- Top for Revenue Growth among peers.<br />
- Bottom for Gross Profit among peers.<br />
- Bottom for Return on Equity among peers.<br />
Overall, Teledyne Technologies shows strong revenue growth but lower profitability and return on equity compared to its peers.</p>
<h3>About Teledyne Technologies</h3>
<p>Teledyne Technologies Inc sells technologies for industrial markets. Roughly a fourth of Teledyne's revenue comes from contracts with the United States government. The firm operates in four segments: instrumentation, digital imaging, aerospace and defense electronics, and engineered systems. The instrumentation segment provides monitoring instruments primarily for marine and environmental applications. The digital imaging segment contributes majority of proportion of revenue and includes image sensors and cameras for industrial, government, and medical customers. The aerospace and defense electronics segment provides electronic components and communication products for aircraft. The engineered systems segment provides solutions for defense, space, environmental, and energy applications.</p>
<h3>A Deep Dive into Teledyne Technologies's Financials</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Teledyne Technologies showcased positive performance, achieving a revenue growth rate of <strong>5.42%</strong> as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Teledyne Technologies's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>13.21%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Teledyne Technologies's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>2.07%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Teledyne Technologies's ROA excels beyond industry benchmarks, reaching <strong>1.38%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Teledyne Technologies's debt-to-equity ratio is below the industry average at <strong>0.28</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/TDY/earnings"><strong>To track all earnings releases for Teledyne Technologies visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insights Ahead: Teledyne Technologies's Quarterly Earnings

<p><strong>MidCap Financial's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MFIC#NYSE">MFIC</a>) short percent of float has fallen 5.81% since its last report. The company recently reported that it has <strong>756 thousand shares sold short</strong>, which is 0.81% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 1.74 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>MidCap Financial Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745337637_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for MidCap Financial has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing MidCap Financial's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, MidCap Financial's peer group average for short interest as a percentage of float is 2.89%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

Trading Ideas

MFIC

What Does the Market Think About MidCap Financial?

<p><strong>Everest Group's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>) short percent of float has risen 21.48% since its last report. The company recently reported that it has <strong>894 thousand shares sold short</strong>, which is 3.28% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.01 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Everest Group Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745337632_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Everest Group has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Everest Group's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Everest Group's peer group average for short interest as a percentage of float is 2.71%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Looking Into Everest Group's Recent Short Interest

<p>In the current market session, <strong>Energy Transfer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>)</strong> share price is at $16.89, after a <strong>1.99%</strong> spike. Moreover, over the past month, the stock fell by <strong>10.62%</strong>, but in the past year, went up by <strong>6.33%</strong>. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2025/1745337627_0.png" alt="Past Year Chart" /></p>

<h3>Energy Transfer P/E Ratio Analysis in Relation to Industry Peers</h3>
<p>The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. </p>
<p>Energy Transfer has a lower P/E than the aggregate P/E of <strong>20.06</strong> of the Oil, Gas &amp; Consumable Fuels industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2025/1745337627_1.png" alt="Guage" /></p>

<p>In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions. </p>


Intraday Update

P/E Ratio Insights for Energy Transfer

<p><strong>Chemours's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CC#NYSE">CC</a>) short percent of float has risen 22.2% since its last report. The company recently reported that it has <strong>12.86 million shares sold short</strong>, which is 12.66% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.71 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Chemours Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745337626_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Chemours has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Chemours's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Chemours's peer group average for short interest as a percentage of float is 5.19%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


How Do Investors Really Feel About Chemours?

<p>Merit Medical Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMSI#NASDAQ">MMSI</a>) has outperformed the market over the past 20 years by 2.48% on an annualized basis producing an average annual return of 10.32%. Currently, Merit Medical Systems has a market capitalization of $5.38 billion. </p>
<p><strong>Buying $1000 In MMSI:</strong> If an investor had bought $1000 of MMSI stock 20 years ago, it would be worth <strong>$7,043.75</strong> today based on a price of $91.00 for MMSI at the time of writing.</p>
<h3>Merit Medical Systems's Performance Over Last 20 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745337626_0_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


MMSI

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

<p><strong>Ross Gerber</strong> has been one of Tesla's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) most vocal investors for years, and while his <a href="https://www.benzinga.com/news/25/04/44685455/tesla-sales-numbers-suck-says-ross-gerber-he-claims-the-tesla-brand-is-broken-because-of-the-board-that-should-be-removed-for-negligence">criticisms of the company's leadership</a> have intensified lately, he still sees Tesla as a critical player in the fight against climate change.</p>
<p>In a recent interview with <a href="https://www.bloomberg.com/news/videos/2025-04-15/gerber-musk-doesn-t-care-about-tesla-video">Bloomberg</a>, Gerber laid it all out. He criticized CEO <strong>Elon Musk's</strong> behavior and its impact on Tesla's stock and reputation, but made it known he hasn't given up on the mission.</p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><strong>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2"><strong>with $1,000 you can invest at just $0.26/share!</strong></a></strong></li>
<li><strong>Invest in the future of digital engagement: <a href="https://www.benzinga.com/money/vatom-adv"><strong>Own a piece of the $100 billion Metaverse for just $500</strong></a>.</strong></li>
</ul>
<h2 class="wp-block-heading">&#8220;I Want to See Tesla Succeed&#8221;</h2>
<p>&#8220;I&#8217;m going to stand up for Tesla because I care about climate,&#8221; Gerber said. &#8220;I want to see Tesla succeed. And that is the whole purpose of why I say these things and get criticized.&#8221;</p>
<p>Gerber, who heads <strong>Gerber Kawasaki Wealth &amp; Investment Management</strong>, said the urgency around climate change became personal after he recently faced a &#8220;horrible fire that was created by climate.&#8221;</p>
<p>&#8220;I can tell you firsthand, after seeing and fighting it myself, that if you&#8217;re not concerned about what climate change is going to do to you, you&#8217;re just being foolish here,&#8221; he said.</p>
<p><strong>Trending: With high-demand properties in the Midwest, Bam Capital has delivered 2.46x equity multiples in just over 3 years. No losses. No missed payments. <a href="https://www.benzinga.com/money/investing-in-the-midwest-why-multifamily-real-estate-is-a-winning-strategy"><strong>Learn more about becoming an investor today</strong></a>.&nbsp;</strong></p>
<p>Tesla&#8217;s image problem</p>
<p>While Gerber still believes in Tesla's products and mission, he said the company is being held back by <a href="https://www.benzinga.com/startups/25/02/43483655/elon-musk-is-all-in-on-trump-tesla-investors-holding-600000-shares-question-if-he-can-still-run-a-1-25-trillion-company">Musk's distractions</a> and political behavior.</p>
<p>&#8220;Nobody&#8217;s made any money in Tesla for a long time,&#8221; he said, pointing to the stock being down around 40% in 2025. &#8220;It&#8217;s clear that [Musk] just doesn&#8217;t care.&#8221;</p>
<p>He also criticized the company for failing to advertise its newer products, like the upgraded Model Y, which Gerber called &#8220;a great upgrade&#8221; and &#8220;way better than the old Model Y.&#8221;</p>
<p>Despite the <a href="https://www.benzinga.com/25/04/44802015/us-electric-vehicle-sales-up-11-in-q1-as-tesla-declines-the-winners-and-losers">setbacks</a>, he maintains that Tesla remains one of the most important companies in the world when it comes to tackling the climate crisis.</p>
<p><strong>Trending: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel"><strong>invest pre-IPO from $0.60 per share now</strong></a></strong><strong>.</strong></p>
<p>Growing pressure on climate research</p>
<p>Gerber's climate-focused stance comes at a time when the Trump administration has begun slashing funding for climate research, including nearly $4 million in grants to Princeton University. The administration&#8217;s <a href="https://www.commerce.gov/news/press-releases/2025/04/ending-cooperative-agreements-funding-princeton-university">press release</a> said the programs increased &#8220;climate anxiety&#8221; and promoted &#8220;implausible climate threats.&#8221;</p>
<p>The funding cuts included support for a Nobel Prize-winning climate modeling program and research into sea-level rise and water availability.</p>
<p>Scientists have warned that weakening climate research efforts could leave the public less informed and less prepared for real environmental risks.</p>
<p>&#8220;Climate-related risks will not vanish if they are denied,&#8221; French climate scientist <strong>Valérie Masson-Delmotte</strong> said in a Bluesky <a href="https://bsky.app/profile/valmasdel.bsky.social/post/3lmenfxb43k2v">post</a>.</p>
<p><strong><em>See Also: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks"><strong><em>One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</em></strong></a></em></strong></p>
<h2 class="wp-block-heading">Tesla Remains a Key Part of Gerber&#8217;s Portfolio</h2>
<p>Despite cutting Tesla exposure in his fund, Gerber said the company is still a core holding for many of his clients.</p>
<p>&#8220;I still own Tesla. We own a lot of Tesla at my firm,&#8221; he said, even though he can&#8217;t &#8220;really even justify owning it&#8221; in his fund at the moment.</p>
<p>For Gerber, the big picture still matters most: &#8220;Tesla&#8217;s one of the most important companies to solving climate.&#8221;</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2"><strong>You can invest today for just $0.26/share with a $1000 minimum.</strong></a></strong></li>
<li><strong><a href="https://www.benzinga.com/money/investing-in-the-midwest-why-multifamily-real-estate-is-a-winning-strategy">This investment company boasts a 33.85% internal rate of return (IRR) for its realized projects, allowing accredited investors to earn passive returns and avoid the headaches of being a landlord.</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


TSLA

You're Just 'Being Foolish' If You Ignore Climate Change, Says Ross Gerber. He Believes Tesla Is Central To The Solution

<p>Piper Sandler  analyst Mark Lear   maintains Magnolia Oil &amp; Gas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGY#NYSE">MGY</a>) with a Neutral and lowers the price target from $26 to $25.</p>


Piper Sandler Maintains Neutral on Magnolia Oil & Gas, Lowers Price Target to $25

<p><strong>Devon Energy Corporation </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) shares are trading higher premarket on Tuesday after the company unveiled a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44918139/devon-energy-unveils-value-enhancing-business-optimization-plan" rel="noreferrer noopener">business optimization strategy</a>.</p>
<p>The company aims to enhance its pre-tax free cash flow by $1.0 billion annually through a comprehensive plan.</p>
<p>The company plans to focus on optimizing field operations, reducing drilling and completion costs, and improving both operating margins and corporate expenses.</p>
<p><strong><em>Also Read</em></strong><em>: <a target="_blank" href="https://www.benzinga.com/25/02/43863129/jpmorgan-weighs-in-on-devon-energy-and-occidental-petroleum-after-earnings" rel="noreferrer noopener">JPMorgan Weighs In On Devon Energy And Occidental Petroleum After Earnings</a></em></p>
<p>Devon&#8217;s business optimization plan includes improvement of $300 million from capital efficiency, $250 million from production optimization, $300 million from commercial opportunities, and $150 million from corporate cost reductions.</p>
<p>The company expects to achieve around 30% of these gains by the end of 2025, with full <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">realization targeted by the end of 2026</a>.</p>
<p><strong>Clay Gaspar</strong>, president and CEO said, &#8220;This is an opportune time for us to take on this initiative, as we leverage recent leadership changes across the organization, bringing fresh perspectives and new ideas. Given the challenging market and shifting competitive landscape, this is the right moment to focus internally and improve our profitability.&#8221;</p>
<p>&#8220;Concurrently, we have implemented technological advancements, including advanced analytics and process automation, that are further enhancing our operating performance. These combined efforts are anticipated to achieve approximately $300 million of cash flow uplift by the end of 2025, reinforcing our financial resilience.&#8221;</p>
<p>The company expects to report first-quarter 2025 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">earnings results on May 7, 2025</a>.</p>
<p>Investors can gain exposure to the stock via&nbsp;<strong>the Invesco Energy&nbsp;Exploration &amp; Production ETF</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PXE#NYSE">PXE</a>) and&nbsp;<strong>the Texas Capital&nbsp;Funds Trust Texas Capital Texas Oil Index ETF</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OILT#NYSE">OILT</a>).</p>
<p><strong>Price Action</strong>: DVN shares are up 5.5% at $31.11 at last check Tuesday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/government/regulations/25/04/44850992/stocks-sink-as-powell-dismisses-fed-put-safety-net-gold-extends-massive-lead-over-nasdaq" target="_blank" rel="noreferrer noopener">Stocks Sink As Powell Dismisses &#8216;Fed Put&#8217; Safety Net, Gold Extends Massive Lead Over Nasdaq</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Equities

Large Cap

Guidance

Movers

OILT

PowerShares ETF Trust Dynamic Energy Exploration & Production Port

Devon Energy Unveils $1 Billion Annual Optimization Plan, Targets Efficiency Gains By 2026

<p>Piper Sandler  analyst Mark Lear   maintains Expand Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>) with a Neutral and raises the price target from $101 to $103.</p>


Piper Sandler Maintains Neutral on Expand Energy, Raises Price Target to $103

Press Releases

Glancy Prongay & Murray LLP Announces Investigation of Talos Energy Inc. (TALO)

Commodities

Talos Energy to Announce Third Quarter 2024 Results on November 11, 2024 and Host Earnings Conference Call on November 12, 2024

Talos Energy Announces Third Quarter 2024 Operational and Financial Results

Talos Energy Sells Additional Stake in Zama to Grupo Carso; Enters into a Cooperation Agreement with Control Empresarial and Terminates Stockholders Rights Plan

Talos Energy Announces Management Changes

Talos Energy Announces Successful Drilling Results at the Katmai West #2 Well in the U.S. Gulf of Mexico

Talos Energy Appoints Paul Goodfellow as President, Chief Executive Officer and Board Member

Talos Energy to Announce Fourth Quarter 2024 Results on February 26, 2025 and Host Earnings Conference Call on February 27, 2025

Talos Energy Announces Fourth Quarter and Full Year 2024 Operational and Financial Results

Talos Energy to Announce First Quarter 2025 Results on May 5, 2025 and Host Earnings Conference Call on May 6, 2025

SHLX

TALO

Black Stone Minerals, L.P. Common units representing limited partner interests

Black Stone Minerals

Civitas Resources

Crescent Energy Company Class A Common Stock

Crescent Energy

Dorchester Minerals, L.P. - Common Units Representing Limited Partnership Interests

Dorchester Minerals

VAALCO Energy

Greenfire Resources

Gulfport Energy Corporation Common Shares

Gulfport Energy

Granite Ridge Resources, Inc. Common Stock

Granite Ridge Resources

HighPeak Energy

Kosmos Energy

Kimbell Royalty Partners Common Units Representing Limited Partner Interests

Kimbell Royalty Partners

Mach Natural Resources LP Common Units representing Limited Partner Interests

Mach Natural Resources

Murphy Oil

Northern Oil & Gas

Permian Basin Royalty Tr

Riley Exploration Permian, Inc. Common Stock

Riley Exploration Permian

Sabine Royalty

SandRidge Energy

SM Energy

Sable Offshore

Sitio Royalties Corp. Class A Common Stock

Sitio Royalties

TXO Partners, L.P. Common Units Representing Limited Partner Interests

TXO Partners

Vital Energy, Inc. Common Stock, par value $0.01 per share

Comments

Talos Energy

Talos Energy (TALO) Options

Talos Energy (NYSE:TALO) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL